Clinical Trial Update: Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance [Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 2 study of combining ibrutinib with R-CHOP followed by ibrutinib maintenance for diffuse large B-cell lymphoma, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Ibrutinib (ibrutinib)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: DLBCL | Phase 2 | Status: ACTIVE_NOT_RECRUITING